DONNA KNIGHT: Open Payments
NPI 1184049926 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 69 payments from 9 companies in 2025. Trend: 2023 $77 · 2024 $1,096 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $285 |
| ABBVIE INC. | 26 | $228 |
| AstraZeneca Pharmaceuticals LP | 6 | $212 |
| Lilly USA, LLC | 6 | $148 |
| Amgen Inc. | 11 | $141 |
| Gilead Sciences, Inc. | 2 | $35 |
| Corcept Therapeutics | 2 | $30 |
| Indivior Inc. | 1 | $23 |
| PFIZER INC. | 1 | $15 |
Products named: Ozempic, VRAYLAR, AIRSUPRA, FARXIGA, Rybelsus, ZEPBOUND, OTEZLA, QULIPTA.
Industry payments across SC — which companies pay providers there.
